AI and Machine Learning Revolutionize Anti-Aging Drug Discovery.

Researchers have developed a deep neural network-based approach to identify small-molecule senolytics, drugs that selectively eliminate senescent cells, which contribute to aging and age-related diseases. The approach was able to identify several new senolytic compounds, which were validated in vitro and in vivo. The study demonstrates the potential of machine learning in drug discovery for aging and age-related diseases.